Three Directors at Baytex Energy Corp bought 50,658 shares at between 3.415USD and 3.420USD. The significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...
A director at GPI S.p.A. bought 2,250 shares at 12.900EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
A director at Roche Bobois SA sold 725 shares at 49.434EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
A director at E-Globe S.p.A bought 36,000 shares at 1.328EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
A director at Global Indemnity Group LLC bought 8,000 shares at 32.468USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
>EBITDAaL au-dessus (Europe), FCF en-dessous (BFR) - CA du T1 2024 en hausse de 0,4% sur un an à 27 942 M€ (consensus 27 993 M€), dont une hausse de 2,9% sur le CA de services tiré par TMUS (+2%) et l'Europe (+7%). L’EBITDAaL du T1 ressort en hausse de 5% à 10 473 M€ (au-dessus du cons. de 10 249 M€) ou +6% à base comparable. Les FCFaL sont en hausse de 3,6% à 3 708 M€ (cons. 3 879 M€), en croissance plus faible en raison des investissements seulement en baisse de 2% ...
Two Directors at Myriad Genetics Inc sold 234,044 shares at between 25.143USD and 25.300USD. The significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...
>FY 2024e outlook confirmed - Grand City (GCP) reported this morning Q1 2024 figures which were in line overall with our expectations. GCP confirmed its FY 2024e FFO guidance of € 175m-€ 185m.Earnings from property lettings increased y-o-y to € 84.2m (+2.5% y-o-y), which was in line with our estimate of € 83.5m. FFO I of € 45.2m decreased by -3.6% y-o-y translating into a FFO I per share of € 0.26 (-5.9% y-o-y), both slightly above our estimates. EPRA NTA per sha...
>Des chiffres T1, légèrement au-dessus des attentes - Avolta publie ce matin de bons chiffres du T1. Le Core revenu groupe ressort à 2784 MCHF, soit une croissance de 18% yoy et une croissance organique de 8.6% (dont +1% d’impact positif lié au timing de Pâques). Les revenus sont ainsi 2% au-dessus des attentes du consensus (i.e. Vara Research) et 1% au-dessus de nos estimations. Par région, on notera la très belle performance de la zone EMEA avec une croissance organ...
A director at Gek Terna S.A. sold 8,000 shares at 16.285EUR and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Five Directors at Evolus Inc sold after exercising options/sold 60,276 shares at between 12.645USD and 12.929USD. The significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the com...
AEGON: 1Q24, new unexpected SBB, underlying OCG better, strong ratios across. Belgian telecoms: Digi to start with mobile. CFE: Preview - forecasting revenue numbers… D'Ieteren: Belron US peer Boyd 1Q24 below consensus, warns on 2Q24 growth. Econocom: Joins consortium formed by Onepoint and Butler Industries to acquire Atos. KBC: 1Q24 better across, special dividend, capital distribution pushed back to 1H25. Syensqo: 1Q24 a touch better, positive earnings momentum confirmed. Umicore:...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.